Abstract
BackgroundChimeric antigen receptor T (CART) cell therapy has resulted in impressive overall response rates in the treatment of cancer.1 However, the durable response to therapy is limited by the development...
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have